Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Biomechanical properties of the patellar tendon in children with heritable connective tissue disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Characterising the proximal patellar tendon attachment and its relationship to skeletal maturity in adolescent ballet dancers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Handgrip strength shows no improvements in geriatric patients with persistent inflammation during hospitalization

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The breaking and making of healthy adult human skeletal muscle in vivo

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Effects of anti-inflammatory (NSAID) treatment on human tendinopathic tissue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Treatment with lipid-lowering drugs, statins, is common all over the world. Lately, the occurrence of spontaneous tendon ruptures or tendinosis have suggested a negative influence of statins upon tendon tissue. But how statins might influence tendons is not clear. In the present study, we investigated the effect of statin treatment on mechanical strength, cell proliferation, collagen content and gene expression pattern in a tendon-like tissue made from human tenocytes in vitro. Human tendon fibroblasts were grown in a 3D tissue culture model (tendon constructs), and treated with either simvastatin or atorvastatin, low or high dose, respectively, for up to seven days. After seven days of treatment, mechanical testing of the constructs was performed. Collagen content and cell proliferation were also determined. mRNA levels of several target genes were measured after one or seven days. The maximum force and stiffness were reduced by both statins after 7 days (p<0.05), while the cross sectional area was unaffected. Further, the collagen content was reduced by atorvastatin (p = 0.01) and the cell proliferation rate was decreased by both types of statins (p<0.05). Statin treatment also introduced increased mRNA levels of MMP-1, MMP-3, MMP-13, TIMP-1 and decreased levels of collagen type 1 and 3. In conclusion, statin treatment appears to have a negative effect on tendon matrix quality as seen by a reduced strength of the tendon constructs. Further, activated catabolic changes in the gene expression pattern and a reduced collagen content indicated a disturbed balance in matrix production of tendon due to statin administration.

OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind12
Tidsskriftsnummer3
Sider (fra-til)e0172797
ISSN1932-6203
DOI
StatusUdgivet - 2017

ID: 52387278